The British Peripheral Nerve Society aims to bring together physicians and scientists interested in peripheral nerve disease in Britain, in order to share information and resources, to improve the management of and research into peripheral nerve disease.
Following on from the successful BPNS instigated study of GBS linked to COVID-19 infection - whhich found no evidence that COVID is a significant trigger for GBS, te society is now encouraging a similar collaborative study of GBS following COVID vaccination (any vaccine). Details can be found in the members pages - HERE (login to access)
Tuesday 4 – Wednesday 5th May 2021
2021 will see our conference move online for the first time. This is a 2-day virtual clinical course on childhood and adult neuromuscular disorders covering a range of disorders including Duchenne’s muscular dystrophy (DMD) and other muscular dystrophies, spinal muscular atrophy, (SMA), neuropathies, myopathies, channelopathies and mitochondrial disorders. This year there will be a particular emphasis on transitional diseases i.e. diseases which start in childhood but need to be managed throughout life including DMD and SMA. Recent advances in therapies for these conditions will be covered.
This 2-day course is designed for paediatric and adult specialists with an interest in neuromuscular diseases. Programme to follow shortly.
BPNS face-to-face outpatient policy
Agreed at BPNS AGM, 6 November 2020, amended 16 January 2021. The latest version of this policy can now be found in the new 'Policies' page under 'About' on the society home page.
The BPNS sees no reason for any patient with any peripheral nerve disease to avoid having any of the COVID-19 vaccines. A commentary on the topic my Mike Lunn can be found HERE. An information sheet giving the Societys official view for concerned patients is HERE.
If you are not yet a member, you can apply here